Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030590 | SCV000053267 | likely benign | Von Hippel-Lindau syndrome | 2011-08-18 | criteria provided, single submitter | curation | Converted during submission to Likely benign. |
Labcorp Genetics |
RCV000459500 | SCV000563226 | likely benign | Chuvash polycythemia; Von Hippel-Lindau syndrome | 2024-01-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001703429 | SCV000714524 | likely benign | not provided | 2019-02-11 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002258781 | SCV002534185 | likely benign | Hereditary cancer-predisposing syndrome | 2021-07-30 | criteria provided, single submitter | curation | |
Ambry Genetics | RCV002258781 | SCV002652739 | likely benign | Hereditary cancer-predisposing syndrome | 2020-08-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000030590 | SCV004841660 | likely benign | Von Hippel-Lindau syndrome | 2023-11-10 | criteria provided, single submitter | clinical testing |